Stacey Jennifer Evans
Insider CIK 1321326 · ATRS SVP, General Counsel & Secty · GRTX See Remarks · CNTX Director · NEOG Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NEOG NEOGEN CORP | A Award deriv | 2026-08-14 | 2026-08-14 | 196,276 | — | $0 | 196,276 | SEC↗ |
| NEOG NEOGEN CORP | A Award | 2026-08-14 | 2026-08-14 | 38,627 | $11.65 | $450.0K | 38,627 | SEC↗ |
| NEOG NEOGEN CORP | A Award deriv | 2026-08-14 | 2026-08-14 | 196,276 | — | $0 | 196,276 | SEC↗ |
| NEOG NEOGEN CORP | A Award | 2026-08-14 | 2026-08-14 | 38,627 | $11.65 | $450.0K | 38,627 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| NEOG NEOGEN CORP | A Award deriv | 2026-05-01 | 2026-05-04 | 89,520 | — | $0 | 89,520 | SEC↗ |
| NEOG NEOGEN CORP | A Award | 2026-05-01 | 2026-05-04 | 39,349 | $9.53 | $375.0K | 39,349 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2025-06-12 | 2025-06-12 | 123,500 | — | $0 | 123,500 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2023-05-31 | 2023-05-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-02-25 | 2023-02-28 | 135,000 | — | $0 | 135,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-10-08 | 2021-10-12 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 142,550 | — | $0 | 142,550 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2015-05-28 | 2015-06-01 | 2,469 | $2.18 | $5.4K | 21,803 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2015-05-28 | 2015-06-01 | 70,239 | — | $0 | 92,042 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-03-10 | 2015-03-12 | 47,000 | — | $0 | 47,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-05-29 | 2014-06-02 | 24,272 | — | $0 | 72,816 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-05-29 | 2014-06-02 | 48,544 | — | $0 | 48,544 | SEC↗ |